Fatigue Intervention Co-design Study in Teenagers and Young Adults With Cancer
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
Fatigue is one of the most common and distressing symptoms in teenage and young adult cancer patients. Despite this, there has been virtually no research evaluating treatment for cancer-related fatigue in this young patient group. The investigators are undertaking a small qualitative study to co-design a fatigue intervention, that will then be evaluated in future research to assess its effectiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2016
CompletedFirst Posted
Study publicly available on registry
March 25, 2016
CompletedStudy Start
First participant enrolled
June 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedMay 22, 2017
May 1, 2017
8 months
March 17, 2016
May 19, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Participant-reported feedback on design content as assessed via interviews
3 months
Participant-reported feedback on design acceptability as assessed via interviews
3 months
Study Arms (1)
Fatigue intervention
EXPERIMENTALFatigue Intervention is to be co-designed by participants, and likely to include education, energy conservation and activity promotion. Participants will also decide the name of the Fatigue Intervention
Interventions
The Fatigue Intervention will include education, energy conservation and activity promotion
Eligibility Criteria
You may qualify if:
- Patients:
- Aged 16-27 with a diagnosis of cancer
- Currently or previously known to the Cambridge Teenage and Young Adult cancer service
- Primary cancer treatment completed within one year of recruitment OR on maintenance treatment for leukaemia.
- A screening score of ≥5 in a 10-item numerical rating scale of fatigue severity over the last month
- Able to give informed consent
- Parents:
- The parent of a patient participant or a patient who would be eligible to participate
- The patient consents to the parent being approached about the study
- The parent is able to give informed consent
You may not qualify if:
- Current participation in another clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Anna Spathislead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Spathis, MA MB BChir
Cambridge University Hospitals NHS Foundation Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Consultant in Palliative Medicine
Study Record Dates
First Submitted
March 17, 2016
First Posted
March 25, 2016
Study Start
June 1, 2016
Primary Completion
February 1, 2017
Study Completion
February 1, 2017
Last Updated
May 22, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share